CD44 and breast carcinoma: Since expression of CD44 is closely related to development of breast cancer and genetic variations in certain genes may affect their expression [19], we hypothesize that variations in CD44 that can theoretically affect its protein expression may be associated with varying risk and prognosis of breast cancer.